Complete remission in a rare pelvic angiosarcoma with liposomal doxorubicin: A comprehensive case report and review of literature
Angiosarcoma, an aggressive sarcoma subtype originating from lymphatic or vascular endothelial cells, is rare, constituting less than 2% of all soft tissue sarcomas. Predominantly affecting adult and elderly patients, it manifests diversely across various anatomical locations, with cutaneous lesions...
Saved in:
| Main Authors: | Truls Gråberg, Andri Papakonstantinou, Felix Haglund de Flon, Ivan Shabo, Ann Morgell, Christina Linder-Straglitto, Inga-Lena Nilsson, Fredrik Karlsson, Robert Bränström |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-02-01
|
| Series: | Rare Tumors |
| Online Access: | https://doi.org/10.1177/20363613251324973 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma
by: Marco Mazzotta, et al.
Published: (2016-01-01) -
Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01) -
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01) -
The use of pegylated liposomal doxorubicin in metastatic soft tissue sarcoma
by: Trang Pham, et al.
Published: (2025-04-01) -
Diffuse Erythematous Follicular Eruption Induced by Pegylated Liposomal Doxorubicin
by: Zhong L, et al.
Published: (2025-04-01)